// App-Quantinova.ai

P389 : Systematic review and meta-analysis of risk factors for recurrent primary sclerosing cholangitis

Researchers

Presenter

  • I Steenstraten

Principal Investigators

  • K Sebib Korkmaz

  • P Trivedi

  • A Inderson

  • B van Hoek

  • M Rodriguez Girondo

  • J Maljaars

Medical Centers

  • LUMC Leiden, Gastroenterology and Hepatology, Leiden, Netherlands

  • National Institute for Health Research (NIHR) Birmingham Biomedical Research Centre (BRC), Birmingham, UK

  • University Hospitals Birmingham, Birmingham, UK

  • University of Birmingham, Institute of Immunology and Immunotherapy, Birmingham, United Kingdom

  • University of Birmingham, Institute of Applied Health Research, United Kingdom

  • LUMC, Department of Biomedical Data Sciences, Leiden, The Netherlands

Locations

  • Netherlands

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Gastroenterology (GU)

Disease

  • Primary sclerosing cholangitis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved